[Pathogenesis of Alzheimer's disease]

Area of Science:

• Neuroscience
• Cell Biology
• Pathology

Context:

• Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive cognitive decline.
• Understanding the early molecular changes in AD is crucial for developing effective treatments.
• Neurofilaments are key components of the neuronal cytoskeleton, and their alterations are implicated in various neurological diseases.

Purpose:

• To investigate the distribution of phosphorylated and non-phosphorylated neurofilaments in cerebral neurons of normal adults and patients with Alzheimer's disease.
• To identify early cytoskeletal changes associated with AD pathogenesis.

Summary:

• This study utilized immunocytochemistry with monoclonal antibodies against 160 and 200 kDa phosphorylated and non-phosphorylated neurofilaments.
• In normal brains, non-phosphorylated neurofilaments were found in the perikarya, while phosphorylated neurofilaments were concentrated in the cell periphery and axons.
• In AD brains, phosphorylated neurofilaments accumulated within neuron cell bodies, whereas non-phosphorylated neurofilaments showed no significant difference compared to controls. No immunoreactivity was observed in senile plaques.

Impact:

• The findings suggest that the accumulation of high molecular weight phosphorylated neurofilaments within neuron cell bodies represents an early pathogenetic event in Alzheimer's disease.
• This discovery could lead to new diagnostic markers or therapeutic targets for AD.
• Highlights the importance of cytoskeletal dynamics in neurodegenerative processes.